Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
7.00
+0.04 (0.57%)
At close: Aug 22, 2025, 4:00 PM
7.00
0.00 (0.00%)
Pre-market: Aug 25, 2025, 8:26 AM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $608.97 million as of August 25, 2025. Its market cap has increased by 256.12% in one year.
Market Cap
608.97M
Enterprise Value
522.34M
1-Year Change
256.12%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $608.97M, an increase of 264.65%. That is a compound annual growth rate of 31.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 598.60M | 110.85% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 644.22B |
| Johnson & Johnson | 434.39B |
| AbbVie | 371.52B |
| UnitedHealth Group | 280.58B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 231.76B |